Familial clustering of factor VIII and von Willebrand factor levels

Thrombosis and Haemostasis

Volumn 79, Issue 2, 1998, Pages 323-327

  Kamphuisen, Pieter W ^a   Houwing Duistermaat, Jeanine J ^a   Van Houwelingen, Hans C ^a   Eikenboom, Jeroen C J ^a   Bertina, Rogier M ^a   Rosendaal, Frits R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BLOOD GROUP ABO SYSTEM; CHILD; CONTROLLED STUDY; FAMILY; FEMALE; GENETIC COUNSELING; HEMOPHILIA A; HUMAN; MAJOR CLINICAL STUDY; MOTHER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RELATIVE; RISK; SIBLING; THROMBOSIS;

EID: 0031885205     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614985     Document Type: Article

References (24)

1. Meade TW, Mellows S, Brozowic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park study. Lancet 1986; ii: 533-7.
2. O'Brien JR. Blood group, von Willebrand's factor and heart disease. Thromb Res 1990; 59: 221.
3. Meade TW, Cooper JA, Stirling Y, Howarth DJ, Ruddock V, Miller GJ. Factor VIII:C, ABO blood group and the incidence of ischaemic heart disease. Br J Haematol 1994; 88: 601-7.
4. Jansson J-H, Nilsson TK, Johnson O. Von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J 1991; 66: 351-5.
5. Rosendaal FR, Varekamp I, Smit C, Bröcker-Vriends HJT, van Dijck H, Vandenbroucke JP, Hermans J, Suurmeijer TPBM, Briët E. Mortality and causes of death in Dutch haemophiliacs, 1973-86. Br J Haematol 1989; 71: 71-6.
6. Triemstra AHM, Rosendaal FR, Smit C, Van der Ploeg HM, Briët E. Mortality in patients with hemophilia. Changes in a Dutch population from 1986 to 1992 and 1973 to 1986. Ann Intern Med 1995; 123: 823-7.
7. Medalie JH, Levene C, Papier C, Goldbourt U, Dreyfuss F, Oron D, Neufeld H, Riss E. Blood groups, myocardial infarction and angina pectoris among 10,000 adult males. N Eng J Med 1973; 285: 1348-53.
8. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691-5.
9. Jeremic M, Weisen O, Gedde-Dahl TW. Factor VIII:C (AHG) levels in 1016 regular blood donors. Scand J Clin Lab Invest 1976; 36: 461-6.
10. Koster T, Blann AD, Briët E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII:C in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995; 345: 1525.
11. Balleisen L, Bailey J, Epping PH, Schulte H, van de Loo J, Epidemiological study on factor VII, factor VIII:C and fibrinogen in an industrial population: I. Baseline data on the relation to age, gender, body weight, smoking, alcohol, pill-using and menopause. Thromb Haemost 1985; 54: 475-9.
12. Balleisen L, Bailey J, Epping PH, Schulte H, van de Loo J. Epidemiological study on factor VII, factor VIII:C and fibrinogen in an industrial population: II. Baseline data on the relation to blood pressure, blood glucose, uric acid and lipid fractions. Thromb Haemost 1985; 54: 721-3.
13. Conlan MG, Folsom AR, Finch A, Davis CE, Sorlie P, Marcucci G, Wu KK. Associations of Factor VIII:C and von Willebrand Factor with age, race, sex, and risk factors for atherosclerosis. Thromb Haemost 1993; 70: 380-5.
14. Tuddenham EGD, Lane RS, Rotblat F, Johnson AJ, Snape TJ, Middleton S, Kernoff PBA. Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease. Br J Haematol 1982; 52: 259-67.
15. Brinkhous KM, Sandberg H, Garris JB, Mattson C, Palm M, Griggs T, Read MS. Purified human factor VIII procoagulant protein: Comparative hemostatic response after infusion into hemophilic and von Willebrand disease dogs. Proc Natl Acad Sci USA 1985; 82: 8752-6.
16. Kerr CB, Preston AE, Barr A, Biggs R. Further studies on the inheritance of factor VIII:C. Br J Haematol 1966; 12: 212-33.
17. Veltkamp JJ, Mayo O, Motulsky AG, Fraser GR. Blood coagulation factors I, II, V, VII, VIII, IX, X, XI and XII in twins. Hum Hered 1972; 22: 102-17.
18. Ørstavik KH, Magnus P, Reisner H, Berg K, Graham JB, Nance W. Factor VIII:C and Factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII:C level. Am J Hum Genet 1985; 37: 89-101.
19. Houwing-Duistermaat JJ, Derkx BHF, Rosendaal FR, Van Houwelingen HC. Testing familial aggregation. Biometrics 1995; 51: 1292-301.
20. Bröcker-Vriends AHJT, Briët E, Quadt R, Dreesen JCFM, Bakker E, Claassen-Tegelaar R, Kanhai HHH, van de Kamp JJP, Pearson PL. Genotype assignment of haemophilia A by use of intragenic and extragenic restriction fragment length polymorphisms. Thromb Haemost 1987; 57: 131-6.
21. Filippi G, Mannucci PM, Coppola R, Farris A, Rinaldi A, Siniscalco M. Studies on Hemophilia A in Sardinia bearing on the problems of multiple allelism, carrier detection, and differential mutation rate in the two sexes. Am J Hum Genet 1984; 36: 44-71.
22. Barrow ES, Graham JB. Blood coagulation Factor VIII (antihemophilic factor): with comments on von Willebrand's disease and Christmas disease. Physiol Rev 1974; 54: 23-74.
23. Sodetz JM, Paulson JC, McKee PA. Carbohydrate composition and identification of blood group A, B, H oligosaccharide structures on human factor VIII/von Willebrand factor. J Biol Chem 1979; 254: 10754-60.
24. Matsui T, Titani K, Mizuochi T. Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor. J Biol Chem 1992; 267: 8723-31.